Equities

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)2.35
  • Today's Change0.04 / 1.73%
  • Shares traded1.50k
  • 1 Year change+32.77%
  • Beta0.7927
Data delayed at least 10 minutes, as of Nov 14 2024 02:13 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue8,2228,2496,908
OPERATING EXPENSES
Cost of revenue total4,6835,0324,215
Selling, general and admin. expenses, total2,4712,3001,904
Depreciation/amortization535153
Unusual expense(income)4755(0.05)
Other operating expenses, total(30)(15)(61)
Total operating expense7,3477,4406,211
Operating income876809697
Other, net(56)(13)(10)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes1,095980873
Provision for income taxes12710786
Net income after taxes969873787
Minority interest18(11)(18)
Net income before extra. Items987862769
Total extraordinary items------
Net income987862769
Inc.avail. to common excl. extra. Items987862769
Inc.avail. to common incl. extra. Items987862769
EPS RECONCILIATION
Basic/primary weighted average shares771773774
Basic/primary eps excl. extra items1.281.110.99
Basic/primary eps incl. extra items1.281.110.99
Dilution adjustment------
Diluted weighted average shares771773774
Diluted eps excl. extra items1.281.110.99
Diluted eps incl. extra items1.281.110.99
COMMON STOCK DIVIDENDS
DPS - common stock primary issue1.150.990.44
Gross dividend - common stock----387
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental18100.10
SUPPLEMENTAL INCOME
Depreciation, supplemental107106107
Total special items4755(0.05)
NORMALISED INCOME
Normalized income before taxes1,1421,035873
Effect of special items on income taxes5.426.020.00
Income tax excluding impact of special items13211386
Normalized income after tax1,010922787
Normalized income avail. to common1,028911769
Basic normalized EPS1.331.180.99
Diluted normalized EPS1.331.180.99
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.